Founded in Seattle, Omeros is a biopharmaceutical company dedicated to discovering, developing, and commercializing small-molecule and protein therapeutics. Their core mission is to address unmet medical needs in inflammation, coagulopathies, and central nervous system (CNS) disorders, targeting both large-market and orphan indications. Omeros offers a deep and diverse pipeline of first-in-class therapies aimed at improving patient outcomes through innovative and data-driven approaches.
Omeros has garnered attention for its groundbreaking work and has attracted notable investors and collaborators in the biopharmaceutical industry. The company’s achievements include the successful development and commercialization of several life-saving therapies. Omeros' impact is significant, providing advanced treatment options for conditions with high unmet needs, thereby enhancing the quality of life for patients worldwide.
